Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.39B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$565M |
| 3 |
Citigroup
C
|
+$429M |
| 4 |
United States Oil Fund
USO
|
+$386M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$378M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$946M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$771M |
| 3 |
Alibaba
BABA
|
+$626M |
| 4 |
Tesla
TSLA
|
+$505M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$421M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.04% |
| 2 | Technology | 2.01% |
| 3 | Communication Services | 1.39% |
| 4 | Financials | 0.98% |
| 5 | Consumer Discretionary | 0.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HEP
3526
DELISTED
Holly Energy Partners, L.P.
HEP
| $2.52M | ﹤0.01% |
179,576
-42,104
| -19% | -$843K |
|
3527
AtriCure
ATRC
$2.47B
| $2.51M | ﹤0.01% |
+74,772
| New | +$2.69M |
|
3528
CALL
Fate Therapeutics
FATE
$291M
| $2.51M | ﹤0.01% |
113,100
-47,800
| -30% | -$1.21M |
|
3529
Invesco Dorsey Wright Consumer Staples Momentum ETF
PSL
$84.3M
| $2.51M | ﹤0.01% |
+44,499
| New | +$3.05M |
|
3530
CALL
UBS Group
UBS
$168B
| $2.51M | ﹤0.01% |
271,300
-43,600
| -14% | -$502K |
|
3531
CALL
First American
FAF
$7.6B
| $2.51M | ﹤0.01% |
59,200
+55,600
| +1,544% | +$3.18M |
|
3532
Sanofi
SNY
$107B
| $2.51M | ﹤0.01% |
+57,424
| New | +$2.75M |
|
3533
CALL
Vanguard Total Bond Market
BND
$161B
| $2.51M | ﹤0.01% |
29,400
+22,700
| +339% | +$1.93M |
|
|
FINV
3534
FinVolution Group
FINV
$803M
| $2.51M | ﹤0.01% |
1,409,435
-18,230
| -1% | -$36.2K |
|
3535
HF Sinclair
DINO
$17.7B
| $2.51M | ﹤0.01% |
102,312
-19,286
| -16% | -$720K |
|
3536
Thomson Reuters
TRI
$46B
| $2.5M | ﹤0.01% |
34,984
+22,139
| +172% | +$1.72M |
|
3537
TC Energy
TRP
$64.4B
| $2.5M | ﹤0.01% |
56,428
+49,840
| +757% | +$2.53M |
|
3538
PUT
Charles River Laboratories
CRL
$13.9B
| $2.5M | ﹤0.01% |
19,800
-7,700
| -28% | -$1.15M |
|
3539
Invesco S&P 500 GARP ETF
SPGP
$2.29B
| $2.49M | ﹤0.01% |
55,845
+50,634
| +972% | +$2.9M |
|
3540
Vanguard S&P 500 Growth ETF
VOOG
$26.9B
| $2.49M | ﹤0.01% |
100,428
+87,690
| +688% | +$2.49M |
|
|
DCPH
3541
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.49M | ﹤0.01% |
60,486
-21,065
| -26% | -$1.17M |
|
|
PVG
3542
PUT
DELISTED
PRETIUM RESOURCES INC.
PVG
| $2.49M | ﹤0.01% |
438,800
-76,500
| -15% | -$654K |
|
|
RNDM
3543
DELISTED
First Trust Developed International Equity Select ETF
RNDM
| $2.49M | ﹤0.01% |
62,627
+23,843
| +61% | +$1.14M |
|
3544
CALL
Trex
TREX
$4.66B
| $2.48M | ﹤0.01% |
62,000
-262,800
| -81% | -$12.3M |
|
|
CPE
3545
DELISTED
Callon Petroleum Company
CPE
| $2.48M | ﹤0.01% |
453,422
+68,954
| +18% | +$1.7M |
|
3546
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
$4.83B
| $2.48M | ﹤0.01% |
95,423
+85,769
| +888% | +$2.63M |
|
3547
CALL
United Natural Foods
UNFI
$2.77B
| $2.48M | ﹤0.01% |
270,300
+246,500
| +1,036% | +$1.95M |
|
|
IPHI
3548
DELISTED
INPHI CORPORATION
IPHI
| $2.48M | ﹤0.01% |
31,330
-52,834
| -63% | -$4.11M |
|
3549
CALL
iShares US Healthcare ETF
IYH
$3.74B
| $2.48M | ﹤0.01% |
66,000
-38,500
| -37% | -$1.58M |
|
|
MPT
3550
Medical Properties Trust
MPT
$2.44B
| $2.48M | ﹤0.01% |
143,222
+86,721
| +153% | +$1.81M |
|
Similar funds
Jeff Yass's Q1 2020 Portfolio in Review
As of Q1 2020, Jeff Yass held 11,456 positions worth $314B, down 9.5% from $347B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q1 2020 filing shows 1,843 new, 4,539 increased, 3,686 reduced and 1,300 closed positions. Its largest new stake was Invesco DB US Dollar Index Bullish Fund: 8,692,802 shares worth $233M. The largest sale was Amazon, an estimated $946M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 89% a quarter earlier, followed by Technology and Communication Services.
- Jeff Yass's largest Q1 2020 buy was Invesco DB US Dollar Index Bullish Fund: 8,692,802 shares worth $233M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $6.39B increase.
- Jeff Yass's biggest Q1 2020 reduction was Amazon, cutting an estimated $946M.
- Jeff Yass fully exited Medicines Co in Q1 2020, selling an estimated $92M.
- Jeff Yass's ten largest holdings make up 30% of its $314B portfolio in Q1 2020.
- Jeff Yass opened 1,843 new positions and closed 1,300 in Q1 2020.
- Jeff Yass's portfolio value fell 9.5% quarter-over-quarter to $314B.
Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.